Skip to content

Lexicon Pharmaceuticals LXRX Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin99.5%+1.5pp99.4%+1.4pp99.4%+5.9pp99.2%+6.7pp98%+3.0pp
Operating margin-34.8%+534pp-98.2%+536pp-94.4%+3,943pp-202.6%+5,210pp-568.6%+7,477pp
Net margin-37.5%+531pp-101.1%+544pp-96.8%+4,042pp-206.4%+5,344pp-568%+7,809pp
Returns
Return on equity-16%+70.1pp-39.7%+128pp-45.9%+90.2pp-65.3%+29.5pp-86.1%+16.6pp
Return on invested capital-13.5%+62.9pp-33.5%+75.4pp-37.5%+51.5pp-52.5%+26.3pp-76.3%+13.0pp
Efficiency
Asset turnover0.2×+0.2×0.2×+0.1×0.3×+0.3×0.2×+0.2×0.1×+0.1×
Liquidity
Current ratio18.8×+16.6×4.9×-0.6×5.6×-1.8×4.2×-7.3×2.2×-13.4×
Leverage
Debt-to-equity0.3×-0.6×0.6×-0.1×0.5×-0.1×0.5×0.0×0.9×+0.5×
Per Share
Book value per share$0.51+49.1%$0.30-35.0%$0.33-33.0%$0.36-53.9%$0.34-71.1%
Valuation
Market capitalization$986.12M+262%$417.91M+56.5%$490.59M-13.6%$279.76M-53.9%$166.58M-71.8%
Price / sales14.2×+5.4×8.4×-0.2×6.9×-102×4.8×-162×5.3×-250×
Price / book4.9×+2.6×3.9×+2.1×4.1×+0.9×2.2×-0.4×1.4×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Lexicon Pharmaceuticals's profit margins?
Lexicon Pharmaceuticals (LXRX) runs a 99.5% gross margin and a -34.8% operating margin, with a -37.5% net margin.
Where do Lexicon Pharmaceuticals's ratios come from?
Every ratio is computed from Lexicon Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.